DESIGN, DEVELOPMENT, AND CHARACTERIZATION OF LORATADINE SUSTAINED RELEASED BUCCAL FILM: IN VITRO AND IN VIVO STUDY IN BEAGLE DOGS

Authors

  • SIHAM A. ABDOUN Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraidah, KSA
  • AMLAK S. ALTUWAYJIRI College of Pharmacy, AL-Qassim University, Buraidah, KSA
  • BUSHRA A. ALFURAYDI College of Pharmacy, AL-Qassim University, Buraidah, KSA
  • KHAWLAH A. ALBURAYH College of Pharmacy, AL-Qassim University, Buraidah, KSA
  • GAMAL O. ELHASSAN Department of Pharmaceutics, Unaizah College of Pharmacy, Qassim University, Unaizah, KSA
  • DALIA A. GABER Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraidah, KSA. Department of Quality Control and Quality Assurance, Holding Company for Biological Products and Vaccines, Cairo, Egypt

DOI:

https://doi.org/10.22159/ijap.2024v16i2.50119

Keywords:

Buccal drug delivery, Mucoadhesive polymers, Loratadine, Films, Bioavailability

Abstract

Objective: The aim of this work was to develop and evaluate bucco-adhesive films of Loratadine (LTD) for sustained release use.

Methods: Design of twelve different sustained released buccal film formulas using Carbopol, pectin, sodium alginate, glycerol, carboxymethyl cellulose (CMC), hydroxypropyl cellulose (HPC), Gelatin, Hydroxyethyl cellulose (HEC), and Hydroxypropyl methylcellulose (HPMC) as mucoadhesive polymers. Films were evaluated for physicochemical properties, thickness, swelling, moisture content, drug content, in vitro dissolution. The pharmacokinetic parameters of optimal formula were evaluated in beagle dogs.

Results: The selected film formula (F6) showed accepted content and muco-adhesion properties. The in vitro release study showed prolonged release of drug from films over 10 h in optimal formulation. The bioavailability studies performed using beagle dogs model showed that there was 113.45% increase in the AUC0-24 of selected film compared with oral market tablets.

Conclusion: Bucco-adhesive films is a promising dosage form for improving the bioavailability of loratadine.

Downloads

Download data is not yet available.

References

Gilhotra RM, Ikram M, Srivastava S, Gilhotra N. A clinical perspective on mucoadhesive buccal drug delivery systems. J Biomed Res. 2014;28(2):81-97. doi: 10.7555/JBR.27.20120136, PMID 24683406.

Pathan SA, Iqbal Z, Sahani JK, Talegaonkar S, Khar RK, Ahmad FJ. Buccoadhesive drug delivery systems-extensive review on recent patents. Recent Pat Drug Deliv Formul. 2008;2(2):177-88. doi: 10.2174/187221108784534135, PMID 19075906.

Ruiz Rubio L, Alonso ML, Perez Alvarez L, Alonso RM, Vilas JL, Khutoryanskiy VV. Formulation of Carbopol®/poly(2-ethyl-2-oxazoline) s mucoadhesive tablets for buccal delivery of hydrocortisone. Polymers. 2018;10(2):175. doi: 10.3390/polym10020175, PMID 30966211.

Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet. 2002;41(9):661-80. doi: 10.2165/00003088-200241090-00003, PMID 12126458.

Abruzzo A, Bigucci F, Cerchiara T, Cruciani F, Vitali B, Luppi B. Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride. Carbohydr Polym. 2012;87(1):581-8. doi: 10.1016/j.carbpol.2011.08.024, PMID 34663007.

Shaikh R, Raj Singh TR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3(1):89-100. doi: 10.4103/0975-7406.76478, PMID 21430958.

Puratchikody A, Prasanth VV, Mathew ST, Ashok KB. Buccal drug delivery: past, present and future-a review. Int J Drug Deliv. 2011;3:171-84.

Kianfar F, Antonijevic MD, Chowdhry BZ, Boateng JS. Formulation development of a carrageenan-based delivery system for buccal drug delivery using ibuprofen as a model drug. J Biomater Nanobiotechnol. 2011;02(5):582-95. doi: 10.4236/jbnb.2011.225070.

Chinna Reddy P, Chaitanya KS, Madhusudan Rao Y. A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods. Daru. 2011;19(6):385-403. PMID 23008684.

Kraisit P, Limmatvapirat S, Nunthanid J, Sriamornsak P, Luangtana Anan M. Preparation and characterization of hydroxypropyl methylcellulose/polycarbophil mucoadhesive blend films using a mixture design approach. Chem Pharm Bull (Tokyo). 2017;65(3):284-94. doi: 10.1248/cpb.c16-00849, PMID 27980251.

Abruzzo A, Bigucci F, Cerchiara T, Cruciani F, Vitali B, Luppi B. Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride. Carbohydr Polym. 2012;87(1):581-8. doi: 10.1016/j.carbpol.2011.08.024, PMID 34663007.

Montero-Padilla S, Velaga S, Morales JO. Buccal dosage forms: general considerations for pediatric patients. AAPS PharmSciTech. 2017;18(2):273-82. doi: 10.1208/s12249-016-0567-2, PMID 27301872.

Jacob S, Nair AB, Patel V, Shah J. 3D printing technologies: recent development and emerging applications in various drug delivery systems. AAPS PharmSciTech. 2020;21(6):220. doi: 10.1208/s12249-020-01771-4, PMID 32748243.

Mythri G, Kavitha K, Kumar MR, Singh SJ. Novel mucoadhesive polymers–a review. J Appl Pharm Sci. 2011;01(08):37-42.

Ponchel G. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev. 1998;34(2-3):191-219. doi: 10.1016/S0169-409X(98)00040-4.

Shinde P, Salunkhe V, Magdum C. Buccal film: an innovative dosage form designed to improve patient compliance. Int J of Pharmaceutical and Chemical Science. 2012;1(4):1262-78.

Arunachalam A, Karthikeyan M, Konam K. Fast dissolving drug delivery: a review. J Glob Trends Pharm Sci. 2010;1(1):92-110.

Mishra A, Pathak AK. Plasticizers: a vital excipient in novel pharmaceutical formulations. Curr Res Pharm Sci. 2017;7(1, May):1-10. doi: 10.24092/CRPS.2017.070101.

Banyal M, Joshi S. Transdermal patch: an innovative technique for transdermal drug delivery system. IJPPR. 2021;20(3):109-31.

Burad S, Markad K, Kulkarni N, Dhole S. Assessment and outcome on preparations, characterization of topical targeted nano sponge based drug delivery: critical review. Asian J Pharm Clin Res. 2023;16(5):19-26.

Park CR, Munday DL. Evaluation of selected polysaccharide excipients in Buc-coadhesive tablets for sustained release of nicotine drug development and Indus BF Pharmacy. 2004;30(6):609-17. PMID 15285334.

Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. J Control Release. 2013;166(1):10-21. doi: 10.1016/j.jconrel.2012.11.019, PMID 23219961.

Mahajan A, Chhabra N, Aggarwal G. Formulation and characterization of fast dissolving buccal films: a review. Scholars Res Libr. 2011;3:152-65.

Chakraborty P, Dey S, Parcha V, Bhattacharya SS, Ghosh A. Design expert supported mathematical optimization and predictability study of buccoadhesive pharmaceutical wafers of loratadine. BioMed Res Int. 2013;2013:197398. doi: 10.1155/2013/197398, PMID 23781498.

Arya A, Sharma V, Pathak K. Pharmaceutical evaluation and dynamic vapor Sorption studies of fast dissolving intraoral films of loratadine. Pharm Dev Technol. 2013;18(6):1329-38. doi: 10.3109/10837450.2012.685659, PMID 22663089.

El-Hammadi M, Awad N. Investigating the use of liquisolid compacts technique to minimize the influence of ph variations on loratadine release. AAPS PharmSciTech. 2012;13(1):53-8. doi: 10.1208/s12249-011-9719-6, PMID 22101967.

Kumria R, Nair AB, Al-Dhubiab BE. Loratidine buccal films for allergic rhinitis: development and evaluation. Drug Dev Ind Pharm. 2014;40(5):625-31. doi: 10.3109/03639045.2014.884125, PMID 24506459.

Elkomy MH, El Menshawe SF, Abou-Taleb HA, Elkarmalawy MH. Loratadine bioavailability via buccal transferosomal gel: formulation, statistical optimization, in vitro/in vivo characterization, and pharmacokinetics in human volunteers. Drug Deliv. 2017;24(1):781-91. doi: 10.1080/10717544.2017.1321061, PMID 28480758.

Pa B, Virsen Tg, Najmuddin M. Formulation and in vitro evaluation of buccal tablets of loratadine for effective treatment of allergy; 2011.

Mura P, Corti G, Cirri M, Maestrelli F, Mennini N, Bragagni M. Development of mucoadhesive films for buccal administration of flufenamic acid: effect of cyclodextrin complexation. J Pharm Sci. 2010;99(7):3019-29. doi: 10.1002/jps.22068, PMID 20127823.

Rajaram DM, Laxman SD. Buccal mucoadhesive films: a review. Syst Rev Pharm. 2016;8(1):31-8. doi: 10.5530/srp.2017.1.7.

Kaur A, Kaur G. Mucoadhesive buccal patches based on interpolymer complexes of chitosan-pectin for delivery of carvedilol. Saudi Pharm J. 2012;20(1):21-7. doi: 10.1016/j.jsps.2011.04.005, PMID 23960773.

Nair AB, Shah J, Jacob S, Al-Dhubiab BE, Patel V, Sreeharsha N. Development of mucoadhesive buccal film for rizatriptan: in vitro and in vivo evaluation. Pharmaceutics. 2021;13(5):728. doi: 10.3390/pharmaceutics13050728, PMID 34063402.

Buanz ABM, Belaunde CC, Soutari N, Tuleu C, Gul MO, Gaisford S. Ink-jet printing versus solvent casting to prepare oral films: effect on mechanical properties and physical stability. Int J Pharm. 2015;494(2):611-8. doi: 10.1016/j.ijpharm.2014.12.032, PMID 25526674.

Khanna R. Preparation and evaluation of bioerodible buccal tablets containing clotrimazole. International Journal of Pharmaceutics. 1996;138(1):67-73. doi: 10.1016/0378-5173(96)04531-0.

Yang TZ, Wang XT, Yan XY, Zhang Q. Phospholipid deformable vesicles for buccal delivery of insulin. Chem Pharm Bull (Tokyo). 2002;50(6):749-53. doi: 10.1248/cpb.50.749, PMID 12045327.

Satishbabu BK, Srinivasan BP. Preparation and evaluation of buccoadhesive films of atenolol. Indian J Pharm Sci. 2008;70(2):175-9. doi: 10.4103/0250-474X.41451, PMID 20046708.

Khurana R, Ahuja A, Khar R. Development and evaluation of mucoadhesive nitrate. Indian J Pharm Sci. 2000;62:447-51.

Verma N, Ghosh AK, Chattopadhyay P. Preparation and in vitro assessment of mucoadhesive buccal patches containing carvedilol. Int J Pharm Pharm Sci. 2011;3(3):218-20.

Desu P, Sahu M. Formulation and evaluation of fast dissolving film of zolmitriptan. Int Res J Pharm. 2012;3(1):373-6.

Shridhar I, Joshi A. Formulation and characterization of buccal patch of Ondanserton hydrochloride. Int J Pharm Res Dev. 2013;5(8):84-94.

El Sharawy AM, Shukr MH, Elshafeey AH. Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation. Drug Deliv. 2017;24(1):1762-9. doi: 10.1080/10717544.2017.1402216, PMID 29172829.

Yehia SA, El-Gazayerly ON, Basalious EB. Fluconazole mucoadhesive buccal films: in vitro/in vivo performance. Curr Drug Deliv. 2009;6(1):17-27. doi: 10.2174/156720109787048195, PMID 19418952.

Amini Hossein, Ahmadiani Abolhassan. Rapid determination of loratadine in small volume plasma samples by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;809(2):227-30. doi: 10.1016/j.jchromb.2004.06.022, PMID 15315769.

Koland M, Charyulu R, Prabhu P. Muco-adhesive films of losartan potassium for buccal delivery: design and characterization. Indian J Pharm Educ. 2010;44:315-23.

Patel VM, Prajapati BG, Patel JK, Patel MM. Physicochemical characterization and evaluation of buccal adhesive patches containing propranolol hydrochloride. Curr Drug Deliv. 2006;3(3):325-31. doi: 10.2174/156720106777731082, PMID 16848734.

Semalty A, Semalty M, Nautiyal U. Formulation and evaluation of mucoadhesive buccal films of enalapril maleate. Indian J Pharm Sci. 2010;72(5):571-5. doi: 10.4103/0250-474X.78522, PMID 21694987.

Kumria R, Nair AB, Goomber G, Gupta S. Buccal films of prednisolone with enhanced bioavailability. Drug Deliv. 2016;23(2):471-8. doi: 10.3109/10717544.2014.920058, PMID 24892626.

Jacob S, Nair AB, Boddu SHS, Gorain B, Sreeharsha N, Shah J. An updated overview of the emerging role of patch and film-based buccal delivery systems. Pharmaceutics. 2021;13(8):1206. doi: 10.3390/pharmaceutics13081206, PMID 34452167.

Pilicheva B, Uzunova Y, Marudova M. Polyelectrolyte multilayer films as a potential buccal platform for drug delivery. Polymers (Basel). 2022;14(4):14(4):734. doi: 10.3390/polym14040734, PMID 35215645.

Gajdosova M, Vetchy D, Muselik J, Gajdziok J, Jurica J, Vetcha M. Bilayer mucoadhesive buccal films with prolonged release of ciclopirox olamine for the treatment of oral candidiasis: in vitro development, ex vivo permeation testing, pharmacokinetic and efficacy study in rabbits. Int J Pharm. 2021;592:120086. doi: 10.1016/j.ijpharm.2020.120086, PMID 33188896.

Published

07-03-2024

How to Cite

ABDOUN, S. A., ALTUWAYJIRI, A. S., ALFURAYDI, B. A., ALBURAYH, K. A., ELHASSAN, G. O., & GABER, D. A. (2024). DESIGN, DEVELOPMENT, AND CHARACTERIZATION OF LORATADINE SUSTAINED RELEASED BUCCAL FILM: IN VITRO AND IN VIVO STUDY IN BEAGLE DOGS. International Journal of Applied Pharmaceutics, 16(2), 106–115. https://doi.org/10.22159/ijap.2024v16i2.50119

Issue

Section

Original Article(s)

Most read articles by the same author(s)